quinacrine has been researched along with Glucosephosphate Dehydrogenase Deficiency in 1 studies
Quinacrine: An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. It is used in cell biological experiments as an inhibitor of phospholipase A2.
quinacrine : A member of the class of acridines that is acridine substituted by a chloro group at position 6, a methoxy group at position 2 and a [5-(diethylamino)pentan-2-yl]nitrilo group at position 9.
Glucosephosphate Dehydrogenase Deficiency: A disease-producing enzyme deficiency subject to many variants, some of which cause a deficiency of GLUCOSE-6-PHOSPHATE DEHYDROGENASE activity in erythrocytes, leading to hemolytic anemia.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kushakovskiĭ, MS | 1 |
1 other study available for quinacrine and Glucosephosphate Dehydrogenase Deficiency
| Article | Year |
|---|---|
[Acute drug-induced hemolytic anemia associated with met- and sulfhemoglobinemia (glucose-6-phosphate dehydrogenase deficiency in the erythrocytes)].
Topics: Adult; Benzocaine; Female; Glucosephosphate Dehydrogenase Deficiency; Humans; Methemoglobinemia; Qui | 1966 |